Related Experiment Video
Updated: Dec 7, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Pre-Gestational Diabetes and Pregnancy Outcomes
Dalal S Ali1,2, Recie Davern1,2,3, Eimear Rutter2
1Endocrinology Department, Mater Misericordiae University Hospital, Dublin, Ireland.
Pregnancy outcomes in women with pre-gestational diabetes show type 2 diabetes is linked to higher BMI and better control. Continuous subcutaneous insulin infusion use correlated with increased miscarriage and malformation rates.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Neonatal Health
Background:
- Pre-gestational diabetes mellitus (PGDM), encompassing type 1 and type 2 diabetes, is a significant risk factor for adverse neonatal outcomes.
- PGDM is also associated with elevated rates of emergency cesarean sections, posing challenges in obstetric management.
Purpose of the Study:
- To investigate pregnancy outcomes in women with pre-gestational diabetes mellitus.
- To compare outcomes between type 1 and type 2 diabetes mellitus.
- To evaluate the impact of different insulin treatment modalities on pregnancy and neonatal outcomes.
Main Methods:
- A cohort study of 174 women with pre-gestational diabetes attending the National Maternity Hospital, Dublin, Ireland (2015-2017).
- Data collected included diabetes type, demographics, glycemic control (HbA1c), insulin delivery method, and pregnancy/neonatal outcomes.
- Statistical analysis was performed to compare outcomes between different groups.
Main Results:
- The cohort comprised 28.6% with type 2 diabetes mellitus (T2DM) and 71.4% with type 1 diabetes mellitus (T1DM).
- Women with T2DM were older, had higher BMI, and shorter diabetes duration but better glycemic control (HbA1c) at booking compared to T1DM.
- Continuous subcutaneous insulin infusion (CSII) use was associated with higher rates of miscarriage and congenital malformations compared to multiple dose injections (MDI).
- Cesarean delivery rate was 45.4%; CSII group had more emergency cesareans, while MDI group had more elective cesareans.
Conclusions:
- Women with PGDM in this cohort were often overweight, older, and had long-standing diabetes.
- T2DM patients exhibited distinct characteristics including higher BMI, older age, shorter diabetes duration, and better glycemic control than T1DM patients.
- CSII treatment was linked to increased adverse fetal outcomes, including miscarriage and congenital malformations.
- Diabetes control generally improved during pregnancy across the cohort.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones

